Serum soluble Fas levels and incidence of biliary tract cancer in a nested case-control study.

Authors

Yasushi Adachi, Masanori Nojima, Yingsong Lin, Yoshiharu Masaki, Ayako Murota, Yasushi Sasaki, Hiroshi Nakase, Kenji Wakai, Mitsuru Mori, Akiko Tamakoshi

Published in

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Sep 04, 2026. Epub Sep 04, 2026.

Abstract

Soluble Fas (sFas) plays multiple roles in tumorigenesis and cancer dissemination by avoiding apoptosis via connection to Fas ligand. We assessed associations of serum sFas levels with the incidence of extrahepatic biliary tract cancer (eBTC) in a prospective case-control study nested in the Japan Collaborative Cohort study.
A baseline survey was conducted from 1988 using blood samples from 39,242 individuals (35% of 110,585). Patients diagnosed with eBTC, before the end of 1997, were regarded as cases. Odds ratios (ORs) for cancer incidence associated with sFas were estimated by conditional logistic regression.
This study included 73 cases and 215 controls. Participants with high sFas showed an elevated risk of cancer (P-trend = 0.01) and the third tertile of sFas showed a higher risk compared to the first tertile (OR 3.27, 95% confidence interval [CI] 1.37-7.80). In both gallbladder and extrahepatic bile duct cancers (n = 33 and 40, respectively), high sFas was associated with elevated risk (P-trend = 0.04 and 0.02, respectively). In women and the non-elderly, subjects in the highest tertiles showed higher cancer risk. Limiting subjects to those followed for over 2 years, high sFas was related to cancer risk (P-trend = 0.02) and the third tertile showed a higher risk compared to the first (OR 3.03, 95%CI 1.14-8.07).
High serum sFas may be related to future risk of eBTC.
These findings highlight the need for additional studies of this biomarker in large prospective cohorts and through integrated analysis involving other cohorts.

PMID:
42696027
Bibliographic data and abstract were imported from PubMed on 05 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.